abstract |
Using gene expression profiling, the present invention identifies ecto-5’-nucleotidase (5’NT) or CD73 as a diagnostic marker and therapeutic target for pancreatic cancer. The invention therefore provides methods for prediction and detection of CD73 associated cancers, and evaluation of inhibitors of CD73. The invention also provides a method of treating or preventing pancreatic cancer in a subject. |